Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.2B | $15.5B | $15.5B | $15.7B | $16.5B | $17.4B | $18.0B | $19.5B | $20.1B | $20.4B |
| Revenue growth | — | 1.7% | 0.6% | 1.0% | 5.0% | 5.8% | 3.1% | 8.3% | 3.3% | 1.4% |
| Gross profit | $9.12B | $9.28B | $9.23B | $9.32B | $10.0B | $10.4B | $10.2B | $11.3B | $12.2B | $12.3B |
| Gross margin | 60.0% | 60.0% | 59.4% | 59.4% | 60.8% | 59.6% | 57.0% | 58.2% | 60.5% | 60.1% |
| Operating income | $3.96B | $3.71B | $3.69B | $3.55B | $3.88B | $3.33B | $2.89B | $3.98B | $4.27B | $3.31B |
| Operating margin | 26.0% | 24.0% | 23.8% | 22.6% | 23.6% | 19.1% | 16.1% | 20.5% | 21.2% | 16.2% |
| Net income | $2.44B | $2.02B | $2.40B | $2.37B | $2.69B | $2.17B | $1.78B | $2.30B | $2.89B | $2.13B |
| Net margin | 16.1% | 13.1% | 15.4% | 15.1% | 16.4% | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% |
| EPS (diluted) | $2.72 | $2.28 | $2.75 | $2.75 | $3.14 | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.14B | $3.05B | $3.06B | $3.13B | $3.72B | $3.33B | $2.56B | $3.75B | $4.11B | $4.20B |
| Capital expenditures | $593M | $553M | $436M | $335M | $410M | $567M | $696M | $705M | $561M | $564M |
| Free cash flow | $2.55B | $2.50B | $2.62B | $2.80B | $3.31B | $2.76B | $1.86B | $3.04B | $3.55B | $3.63B |
| Share buybacks | $1.33B | $1.40B | $1.24B | $1.20B | $1.48B | $1.32B | $1.31B | $1.13B | $1.74B | $1.21B |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.31B | $1.53B | $726M | $883M | $888M | $832M | $775M | $966M | $1.10B | $1.29B |
| Total assets | $12.1B | $12.7B | $12.2B | $15.0B | $15.9B | $15.0B | $15.7B | $16.4B | $16.0B | $16.3B |
| Total liabilities | $12.1B | $12.4B | $12.0B | $14.5B | $14.8B | $14.1B | $14.9B | $15.4B | $15.5B | $16.0B |
| Long-term debt | $6.52B | $6.57B | $6.35B | $7.33B | $7.33B | $7.19B | $8.74B | $8.22B | $7.29B | $6.87B |
| Shareholders' equity | -$243M | -$60.0M | -$102M | $117M | $743M | $609M | $401M | $609M | $212M | $54.0M |
| Retained earnings | $19.9B | $20.5B | $21.6B | $22.5B | $23.7B | $24.4B | $24.6B | $25.3B | $26.1B | $26.6B |
| Shares (wtd avg diluted) | 898M | 888M | 873M | 861M | 859M | 848M | 839M | 829M | 823M | 811M |
Every figure is extracted from COLGATE PALMOLIVE CO’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.